StockData
Ernexa Therapeutics Inc. logo

Ernexa Therapeutics Inc. (ERNA) stock

ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.69+0.01 (+0.60%)

Close on Nov 16, 2026Market cap $2.76MP/E –Yield –

Ernexa Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Ernexa Therapeutics's total debt was $2.03M at Dec 31, 2020. For fiscal 2020 it was $2.03M, down 25.8% from the year before. The highest annual figure on record is $8.11M in fiscal 2016.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$2.03M-25.8%
FY2019Dec 31, 2019$2.74M-26.5%
FY2018Dec 31, 2018$3.73M-26.4%
FY2017Dec 31, 2017$5.07M-37.5%
FY2016Dec 31, 2016$8.11M+9.0%
FY2015Dec 31, 2015$7.44M+39.8%
FY2014Dec 31, 2014$5.32M+233.9%
FY2013Dec 31, 2013$1.59M+2175.7%
FY2012Dec 31, 2012$70.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$2.03M-25.8%
Q3 FY2020Sep 30, 2020$3.35M+12.1%
Q2 FY2020Jun 30, 2020$3.25M-2.2%
Q1 FY2020Mar 31, 2020$1.99M-42.8%
Q4 FY2019Dec 31, 2019$2.74M-26.5%
Q3 FY2019Sep 30, 2019$2.99M-26.8%
Q2 FY2019Jun 30, 2019$3.32M-29.7%
Q1 FY2019Mar 31, 2019$3.48M-28.9%
Q4 FY2018Dec 31, 2018$3.73M-26.4%
Q3 FY2018Sep 30, 2018$4.08M-22.3%
Q2 FY2018Jun 30, 2018$4.72M-13.6%
Q1 FY2018Mar 31, 2018$4.89M-36.9%
Q4 FY2017Dec 31, 2017$5.07M-37.5%
Q3 FY2017Sep 30, 2017$5.25M-34.2%
Q2 FY2017Jun 30, 2017$5.46M–
Q1 FY2017Mar 31, 2017$7.75M–
Q4 FY2016Dec 31, 2016$8.11M–
Q3 FY2016Sep 30, 2016$7.99M–

More Ernexa Therapeutics figures

See a number that looks wrong?